Fifth Eye nabs $11.5M for clinical early warning system
The Ann Arbor, Michigan-based startup intends to use the funding to secure FDA clearance of its first product, which works to detect the emergence of hemodynamic instability.
The Ann Arbor, Michigan-based startup intends to use the funding to secure FDA clearance of its first product, which works to detect the emergence of hemodynamic instability.
From early Alzheimer's detection to tracking a cancer patient's treatment response, these five Y Combinator startups are changing the healthcare landscape.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A recent FBI alert notes that cybercriminals have been targeting File Transfer Protocol servers to access patient data.
Strata Oncology might be the missing piece in personalized cancer care. The company plans to sequence 100,000 tumor samples for free, matching eligible patients with ongoing pharma trials. Patients, pharma and Strata all win -- if they can pull it off.